ライフサイエンスコーパス: blood group A

1 g complex lactoside carbohydrates resembling blood group A.

2 Blood groups A, AB and B significantly reduced IE bindin

3 3)-N-acetylgalactosamine residues from human blood group A and AB mucin glycoproteins, Forssman hapte

4 We show that mAb F77 can also bind to blood group A and B analogs but with lower intensities.

5 rase (GTB) catalyze the final step in ABO(H) blood group A and B antigen synthesis through sugar tran

6 Recombinant E-ABase not only destroyed the blood group A and B antigenicity of human type A and B e

7 Histo-blood group A and B antigens are oligosaccharide antigen

8 stimulated to secrete substantial amounts of blood group A and B antigens linked to von Willebrand fa

9 lates gastrointestinal mucosal expression of blood group A and B antigens) (rs602662, P=3.4x10(-5)).

10 anti-blood group antibodies interacting with blood group A and B antigens.

11 e enzymes responsible for synthesis of histo-blood group A and B antigens.

12 nal step of the biosynthesis of ABO(H) human blood group A and B antigens.

13 glycosyltransferases that includes the histo blood group A and B enzymes.

14 glycosyltransferases that includes the histo-blood group A and B glycosyltransferases, Forssman glyco

15 ha1-->2)Gal) from glycoconjugates containing blood group A and B glycotopes, respectively.

16 igands supported this preference over type 1 blood group A and B oligosaccharides.

17 Four of five patients were blood group A and had no significant comorbid conditions

18 nthesis of oligosaccharides similar to human blood group A and may participate in the synthesis of th

19 cause in-hospital mortality in patients with blood group A and O who were transfused.

20 wing immunocytochemical markers were tested: blood group A and precursors of blood antigens; laminin

21 The carbohydrate antigens, blood groups A and B, and the alpha-gal epitope (Galalph

22 d no longer than 7 days, both in patients of blood groups A and O and all patients.

23 ytes, but also released A-Tri and B-Tri from blood group A(+)- and B(+)- containing glycoconjugates.

24 l for studying the structure and function of blood group A- and B-containing glycoconju-gates as well

25 functionalized with immunoglobulin G against blood group A (anti-A IgG) by forming a self-assembled m

26 In analogy with histo-blood group A antigen, Forssman (Fs) antigen terminates

27 bodies against alpha-gustducin and the human blood group A antigen.

28 ncogene at codon 12 and all tumors expressed blood group A antigen.

29 monstrating its versatility for synthesis of blood group A antigens.

30 n for anitgen-negative donors, 6) to resolve blood group A, B, and D typing discrepancies, 7) to dete

31 ound sulfated disaccharides as well as human blood groups A, B, and H on both N-glycans and linear gl

32 Incompatibility of the major blood groups A, B, and O has been an absolute contraindi

33 ythrocytes was insensitive to differences in blood groups A, B, O, or MN.

34 Acbeta3Galalpha4Galbeta4Glcbeta1Cer), i.e. a blood group A determinant on a type 4 core chain.

35 ulfated and methylated variants of the histo-blood group A epitope.

36 recombinant lectin, rCNL, agglutinates human blood group A erythrocytes and is specific for the uniqu

37 B6 wild-type (WT) mice were sensitized with blood group A-human erythrocytes; others received passiv

38 To cleave blood group A immunodeterminants from erythrocytes, we p

39 AB mucin glycoproteins, Forssman hapten, and blood group A lacto series glycolipids.

40 des by remodeling blood group B mimicry into blood group A mimicry.

41 The accuracy for detecting blood group A (n=12), B (n=13), AB (n=9), O (n=14), and

42 Thr residues in the tandem repeat domains of blood group A-negative porcine submaxillary gland mucin.

43 asite glycans structurally distinct from the blood group A oligosaccharides on the hemocyte surface m

44 that CvGal1 preferentially recognizes type 2 blood group A oligosaccharides.

45 on-associated carbohydrate antigens, such as blood group A or B and the alpha-gal epitope (Gal(alpha)

46 pes of the same lines transfected with histo-blood group A or B genes.

47 zyme-linked immunosorbent assay (ELISA) with blood group A or B human red cell membranes, as solid ph

48 Blood group A or B patients had lower antibody levels th

49 sitization, donor blood group O to recipient blood group A or B transfer, and ciclosporin treatment h

50 lood stored 7 days or less (in patients with blood group A or O: 0.92, 0.74-1.15, p=0.48; in all 0.90

51 blood product use history (in patients with blood group A or O: hazard ratio 0.94, 95% CI 0.73-1.20,

52 al blood type donor (P = .01), recipient non-blood group A (P = .02), and donor cause of death other

53 ors for parasite invasion, such as the Duffy blood group, a receptor for Plasmodium vivax, and the Ge

54 for all B recipients, even shorter than for blood group A recipients (median waiting times of A2/A2B

55 lated specificity, such as B cells with anti-blood group A specificity.

56 ereus galectin shows particular affinity for blood group A structures.

57 Blood group A subjects had higher levels of anti-pig IgM

58 galectin for N-acetyllactosamine, the human blood group A tetrasaccharide and Galbeta1,3GalNAc relat

59 Histo-blood group A transferase produces A antigens and transf

60 A bacterial version of human blood group A transferase was identified and found to be

61 osylceramide) were identified as well as the blood group A type 1 hexaosylceramide.

62 Recipients with blood group A were also more likely to develop IEC-defin